Document is current
Any future updates will be listed below
-
Authors
Oliver, Walter
Giugliano, Robert P.
- License Information
-
More Information
Article History
Accepted: 11 January 2023
First Online: 10 February 2023
Declarations
:
: Dr. Oliver has no conflict of interest. Dr. Giugliano discloses research grant support to his institution from Merck for the conduct of the IMPROVE-IT Clinical trial, research grant support from Amgen and Ionis to his institution for clinical trials with novel lipid-lowering therapies, honoraria for lectures, CME programs or consulting from Academic CME, Amarin, Amgen, Daiichi Sankyo, Dr. Reddy’s Laboratories, Esperion, Medical Education Resources, Medscape, Menarini, Novartis, Pfizer, Sanofi, SUMMEET, and Voxmedia.
: All patients participating in the IMPROVE-IT clinical trial signed written informed consent.
